KR102138723B1 - Lincrna-결핍 비인간 동물 - Google Patents

Lincrna-결핍 비인간 동물 Download PDF

Info

Publication number
KR102138723B1
KR102138723B1 KR1020167002367A KR20167002367A KR102138723B1 KR 102138723 B1 KR102138723 B1 KR 102138723B1 KR 1020167002367 A KR1020167002367 A KR 1020167002367A KR 20167002367 A KR20167002367 A KR 20167002367A KR 102138723 B1 KR102138723 B1 KR 102138723B1
Authority
KR
South Korea
Prior art keywords
lincrna
nucleic acid
human animal
locus
lncrna
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
KR1020167002367A
Other languages
English (en)
Korean (ko)
Other versions
KR20160035585A (ko
Inventor
카-만 비너스 라이
궈춘 공
죤 린
데이비드 프렌듀이
데이비드 엠. 발렌주엘라
Original Assignee
리제너론 파마슈티칼스 인코포레이티드
프레지던트 앤드 펠로우즈 오브 하바드 칼리지
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 리제너론 파마슈티칼스 인코포레이티드, 프레지던트 앤드 펠로우즈 오브 하바드 칼리지 filed Critical 리제너론 파마슈티칼스 인코포레이티드
Priority to KR1020207021344A priority Critical patent/KR102350200B1/ko
Publication of KR20160035585A publication Critical patent/KR20160035585A/ko
Application granted granted Critical
Publication of KR102138723B1 publication Critical patent/KR102138723B1/ko
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K67/00—Rearing or breeding animals, not otherwise provided for; New or modified breeds of animals
    • A01K67/027—New or modified breeds of vertebrates
    • A01K67/0275—Genetically modified vertebrates, e.g. transgenic
    • A01K67/0276—Knock-out vertebrates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61D—VETERINARY INSTRUMENTS, IMPLEMENTS, TOOLS, OR METHODS
    • A61D19/00—Instruments or methods for reproduction or fertilisation
    • A61D19/04—Instruments or methods for reproduction or fertilisation for embryo transplantation
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/8509—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells for producing genetically modified animals, e.g. transgenic
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0603—Embryonic cells ; Embryoid bodies
    • C12N5/0606—Pluripotent embryonic cells, e.g. embryonic stem cells [ES]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0696—Artificially induced pluripotent stem cells, e.g. iPS
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/07—Animals genetically altered by homologous recombination
    • A01K2217/075—Animals genetically altered by homologous recombination inducing loss of function, i.e. knock out
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/07—Animals genetically altered by homologous recombination
    • A01K2217/075—Animals genetically altered by homologous recombination inducing loss of function, i.e. knock out
    • A01K2217/077—Animals genetically altered by homologous recombination inducing loss of function, i.e. knock out heterozygous knock out animals displaying phenotype
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2227/00—Animals characterised by species
    • A01K2227/10—Mammal
    • A01K2227/105—Murine
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2267/00—Animals characterised by purpose
    • A01K2267/03—Animal model, e.g. for test or diseases
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2267/00—Animals characterised by purpose
    • A01K2267/03—Animal model, e.g. for test or diseases
    • A01K2267/0393—Animal model comprising a reporter system for screening tests
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/178—Oligonucleotides characterized by their use miRNA, siRNA or ncRNA

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • General Engineering & Computer Science (AREA)
  • Environmental Sciences (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Animal Behavior & Ethology (AREA)
  • Reproductive Health (AREA)
  • Developmental Biology & Embryology (AREA)
  • Analytical Chemistry (AREA)
  • Biodiversity & Conservation Biology (AREA)
  • Animal Husbandry (AREA)
  • Transplantation (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Public Health (AREA)
  • Immunology (AREA)
  • Plant Pathology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
KR1020167002367A 2013-08-07 2014-08-07 Lincrna-결핍 비인간 동물 Active KR102138723B1 (ko)

Priority Applications (1)

Application Number Priority Date Filing Date Title
KR1020207021344A KR102350200B1 (ko) 2013-08-07 2014-08-07 Lincrna-결핍 비인간 동물

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201361863147P 2013-08-07 2013-08-07
US61/863,147 2013-08-07
PCT/US2014/050178 WO2015021298A2 (en) 2013-08-07 2014-08-07 Lincrna-deficient non-human animals

Related Child Applications (2)

Application Number Title Priority Date Filing Date
KR1020177001244A Division KR101853466B1 (ko) 2013-08-07 2014-08-07 Lincrna-결핍 비인간 동물
KR1020207021344A Division KR102350200B1 (ko) 2013-08-07 2014-08-07 Lincrna-결핍 비인간 동물

Publications (2)

Publication Number Publication Date
KR20160035585A KR20160035585A (ko) 2016-03-31
KR102138723B1 true KR102138723B1 (ko) 2020-07-29

Family

ID=52449819

Family Applications (3)

Application Number Title Priority Date Filing Date
KR1020177001244A Active KR101853466B1 (ko) 2013-08-07 2014-08-07 Lincrna-결핍 비인간 동물
KR1020167002367A Active KR102138723B1 (ko) 2013-08-07 2014-08-07 Lincrna-결핍 비인간 동물
KR1020207021344A Expired - Fee Related KR102350200B1 (ko) 2013-08-07 2014-08-07 Lincrna-결핍 비인간 동물

Family Applications Before (1)

Application Number Title Priority Date Filing Date
KR1020177001244A Active KR101853466B1 (ko) 2013-08-07 2014-08-07 Lincrna-결핍 비인간 동물

Family Applications After (1)

Application Number Title Priority Date Filing Date
KR1020207021344A Expired - Fee Related KR102350200B1 (ko) 2013-08-07 2014-08-07 Lincrna-결핍 비인간 동물

Country Status (19)

Country Link
US (3) US9554564B2 (enExample)
EP (2) EP3178928B1 (enExample)
JP (6) JP6998656B2 (enExample)
KR (3) KR101853466B1 (enExample)
CN (2) CN112715485A (enExample)
AU (3) AU2014305873B2 (enExample)
BR (1) BR112016002385A2 (enExample)
CA (1) CA2917714A1 (enExample)
DK (1) DK3178928T3 (enExample)
ES (1) ES2812242T3 (enExample)
HK (1) HK1220990A1 (enExample)
IL (2) IL294443A (enExample)
MX (3) MX369452B (enExample)
MY (2) MY198884A (enExample)
NZ (1) NZ716168A (enExample)
RU (1) RU2721855C2 (enExample)
SG (2) SG10201803766UA (enExample)
WO (1) WO2015021298A2 (enExample)
ZA (1) ZA201600170B (enExample)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2020508073A (ja) * 2017-02-27 2020-03-19 リジェネロン・ファーマシューティカルズ・インコーポレイテッドＲｅｇｅｎｅｒｏｎ Ｐｈａｒｍａｃｅｕｔｉｃａｌｓ， Ｉｎｃ． 網膜分離症の非ヒト動物モデル
US20200246488A1 (en) * 2017-07-17 2020-08-06 The Broad Institute, Inc. Compositions and methods for treating inflammatory bowel diseases
US11555199B2 (en) * 2017-09-19 2023-01-17 Tropic Biosciences UK Limited Modifying the specificity of plant non-coding RNA molecules for silencing gene expression
WO2019118879A1 (en) * 2017-12-14 2019-06-20 Donald Danforth Plant Science Center Homologous recombination via transcriptional activation
CN108728545A (zh) * 2018-06-25 2018-11-02 汕头大学医学院附属肿瘤医院 结直肠癌长链非编码rna-hotair分子标志物及其应用
CN108866198B (zh) * 2018-08-31 2020-08-11 青岛泱深生物医药有限公司 标志物loc105376380在直肠腺癌诊断和治疗中的应用
CN108950000B (zh) * 2018-08-31 2020-08-04 青岛泱深生物医药有限公司 lncRNA在直肠腺癌诊疗中的应用
CN108950001B (zh) * 2018-08-31 2020-08-11 青岛泱深生物医药有限公司 一种与直肠腺癌发生发展相关的分子标志物
CN111218451B (zh) * 2020-02-05 2021-08-10 华中农业大学 一种提高猪肌肉量的方法
RU2752663C1 (ru) * 2020-05-18 2021-07-29 ОБЩЕСТВО С ОГРАНИЧЕННОЙ ОТВЕТСТВЕННОСТЬЮ "СберМедИИ" Способ квантификации статистического анализа альтернативного сплайсинга в данных рнк-сек
JPWO2022138421A1 (enExample) * 2020-12-22 2022-06-30
USD1010297S1 (en) * 2021-06-30 2024-01-09 Puma SE Shoe
CN113999873B (zh) * 2021-12-31 2022-05-20 北京市疾病预防控制中心 一种基因修饰的非人动物的构建方法及其应用

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101619312A (zh) 2009-07-10 2010-01-06 四川大学 人黑色素瘤细胞特异表达的长非编码rna序列及其用途
US20120004278A1 (en) 2010-06-18 2012-01-05 The Board Of Trustees Of The Leland Stanford Junior University Linc rnas in cancer diagnosis and treatment
WO2012018881A2 (en) 2010-08-03 2012-02-09 Alnylam Pharmaceuticals, Inc. Methods and compositions for the regulation of rna
US20130267575A1 (en) 2012-03-07 2013-10-10 The Texas A&M University System Cancer treatment targeting non-coding rna overexpression

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6596541B2 (en) 2000-10-31 2003-07-22 Regeneron Pharmaceuticals, Inc. Methods of modifying eukaryotic cells
US6586251B2 (en) 2000-10-31 2003-07-01 Regeneron Pharmaceuticals, Inc. Methods of modifying eukaryotic cells
US7105348B2 (en) 2000-10-31 2006-09-12 Regeneron Pharmaceuticals, Inc. Methods of modifying eukaryotic cells
PL2767161T3 (pl) 2004-10-19 2018-09-28 Regeneron Pharmaceuticals, Inc. Sposób wytwarzania zwierzęcia homozygotycznego pod względem modyfikacji genetycznej
CN101633923B (zh) * 2009-07-10 2011-04-13 四川大学 人黑色素瘤细胞相关的长非编码rna及其用途
RU2425880C2 (ru) * 2009-07-30 2011-08-10 Учреждение Российской академии наук Институт общей генетики им. Н.И. Вавилова РАН Способ получения трансгенных мышей
WO2011020005A1 (en) 2009-08-14 2011-02-17 Regeneron Pharmaceuticals, Inc. miRNA-REGULATED DIFFERENTIATION-DEPENDENT SELF-DELETING CASSETTE
TR201903376T4 (tr) 2009-10-29 2019-04-22 Regeneron Pharma Çok fonksiyonlu alleller.
CN109913495B (zh) 2013-02-20 2022-11-25 瑞泽恩制药公司 大鼠的遗传修饰
SG10201808935WA (en) 2013-04-16 2018-11-29 Regeneron Pharma Targeted modification of rat genome
IL274285B (en) * 2015-03-16 2022-07-01 Regeneron Pharma Non-human animal exhibiting diminished upper and lower motor neuron function and sensory perception

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101619312A (zh) 2009-07-10 2010-01-06 四川大学 人黑色素瘤细胞特异表达的长非编码rna序列及其用途
US20120004278A1 (en) 2010-06-18 2012-01-05 The Board Of Trustees Of The Leland Stanford Junior University Linc rnas in cancer diagnosis and treatment
WO2012018881A2 (en) 2010-08-03 2012-02-09 Alnylam Pharmaceuticals, Inc. Methods and compositions for the regulation of rna
US20130267575A1 (en) 2012-03-07 2013-10-10 The Texas A&M University System Cancer treatment targeting non-coding rna overexpression

Non-Patent Citations (6)

* Cited by examiner, † Cited by third party
Title
Development, vol.137(16), pp.2643-2652(2010).
Developmental Cell, vol.24(2), pp.206-214(2013).
eLife. 2013; 2: e01749(2013.12.31)
Nature Biothechnology, vol.21(6), pp.652-659(2003).
PLoS Genet. vol. 7(9), e1002248(Epub 2011 Sep 1)
Trangenic Research, vol.23, pp.201-250(2013).

Also Published As

Publication number Publication date
AU2017200183B2 (en) 2018-02-01
MY182065A (en) 2021-01-18
RU2721855C2 (ru) 2020-05-25
AU2014305873A1 (en) 2016-02-04
KR20160035585A (ko) 2016-03-31
NZ716168A (en) 2022-05-27
US11547100B2 (en) 2023-01-10
KR101853466B1 (ko) 2018-04-30
JP6998656B2 (ja) 2022-02-04
IL294443A (en) 2022-09-01
IL243581A0 (en) 2016-03-31
US20150047062A1 (en) 2015-02-12
KR20200090977A (ko) 2020-07-29
EP3030653A4 (en) 2017-07-26
MX2019013309A (es) 2020-07-28
MX2022013409A (es) 2022-11-14
AU2018200281B2 (en) 2020-10-08
CN105518132A (zh) 2016-04-20
JP2024164230A (ja) 2024-11-26
RU2016107434A (ru) 2017-09-15
ZA201600170B (en) 2022-03-30
JP2022125255A (ja) 2022-08-26
KR102350200B1 (ko) 2022-01-14
BR112016002385A2 (pt) 2017-09-12
EP3178928B1 (en) 2020-06-10
JP2017099407A (ja) 2017-06-08
JP6192865B2 (ja) 2017-09-06
JP2019037253A (ja) 2019-03-14
MX369452B (es) 2019-11-08
SG11201600036QA (en) 2016-02-26
WO2015021298A2 (en) 2015-02-12
AU2018200281A1 (en) 2018-02-01
MX2016001682A (es) 2017-04-13
SG10201803766UA (en) 2018-06-28
DK3178928T3 (da) 2020-08-24
CA2917714A1 (en) 2015-02-12
CN112715485A (zh) 2021-04-30
AU2014305873B2 (en) 2017-08-31
IL243581B (en) 2022-08-01
JP2020108409A (ja) 2020-07-16
ES2812242T3 (es) 2021-03-16
WO2015021298A3 (en) 2015-04-02
CN105518132B (zh) 2021-02-05
EP3030653A2 (en) 2016-06-15
AU2017200183A1 (en) 2017-02-02
US20230189771A1 (en) 2023-06-22
US20170071173A1 (en) 2017-03-16
HK1220990A1 (zh) 2017-05-19
US9554564B2 (en) 2017-01-31
JP2016526924A (ja) 2016-09-08
MY198884A (en) 2023-10-02
EP3178928A1 (en) 2017-06-14
KR20170012567A (ko) 2017-02-02
AU2017200183C1 (en) 2023-04-27

Similar Documents

Publication Publication Date Title
KR102138723B1 (ko) Lincrna-결핍 비인간 동물
NZ716168A9 (en) Lincrna-deficient non-human animals
EP3367785A2 (en) Compositions and methods for chimeric embryo-assisted organ production
JP2022048157A (ja) 上位及び下位運動ニューロン機能並びに知覚の減衰を示す非ヒト動物
HK1238673A1 (en) Pint knockout mouse exhibiting a premature aging-associated phenotype
Noakes Creation of transgenic mice
HK1238673B (en) Pint knockout mouse exhibiting a premature aging-associated phenotype
JP2004242557A (ja) 筋ジストロフィー症の病態モデル哺乳動物、及びその製造方法
JP2010158181A (ja) トランスジェニック非ヒト動物

Legal Events

Date Code Title Description
PA0105 International application

Patent event date: 20160127

Patent event code: PA01051R01D

Comment text: International Patent Application

PG1501 Laying open of application
A107 Divisional application of patent
AMND Amendment
PA0104 Divisional application for international application

Comment text: Divisional Application for International Patent

Patent event code: PA01041R01D

Patent event date: 20170116

AMND Amendment
A201 Request for examination
A302 Request for accelerated examination
AMND Amendment
PA0201 Request for examination

Patent event code: PA02012R01D

Patent event date: 20190807

Comment text: Request for Examination of Application

PA0302 Request for accelerated examination

Patent event date: 20190807

Patent event code: PA03022R01D

Comment text: Request for Accelerated Examination

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

Comment text: Notification of reason for refusal

Patent event date: 20191015

Patent event code: PE09021S01D

AMND Amendment
E601 Decision to refuse application
PE0601 Decision on rejection of patent

Patent event date: 20200228

Comment text: Decision to Refuse Application

Patent event code: PE06012S01D

Patent event date: 20191015

Comment text: Notification of reason for refusal

Patent event code: PE06011S01I

AMND Amendment
PX0901 Re-examination

Patent event code: PX09011S01I

Patent event date: 20200228

Comment text: Decision to Refuse Application

Patent event code: PX09012R01I

Patent event date: 20191212

Comment text: Amendment to Specification, etc.

Patent event code: PX09012R01I

Patent event date: 20190807

Comment text: Amendment to Specification, etc.

Patent event code: PX09012R01I

Patent event date: 20170803

Comment text: Amendment to Specification, etc.

Patent event code: PX09012R01I

Patent event date: 20170116

Comment text: Amendment to Specification, etc.

PX0701 Decision of registration after re-examination

Patent event date: 20200429

Comment text: Decision to Grant Registration

Patent event code: PX07013S01D

Patent event date: 20200327

Comment text: Amendment to Specification, etc.

Patent event code: PX07012R01I

Patent event date: 20200228

Comment text: Decision to Refuse Application

Patent event code: PX07011S01I

Patent event date: 20191212

Comment text: Amendment to Specification, etc.

Patent event code: PX07012R01I

Patent event date: 20190807

Comment text: Amendment to Specification, etc.

Patent event code: PX07012R01I

Patent event date: 20170803

Comment text: Amendment to Specification, etc.

Patent event code: PX07012R01I

Patent event date: 20170116

Comment text: Amendment to Specification, etc.

Patent event code: PX07012R01I

X701 Decision to grant (after re-examination)
A107 Divisional application of patent
GRNT Written decision to grant
PA0104 Divisional application for international application

Comment text: Divisional Application for International Patent

Patent event code: PA01041R01D

Patent event date: 20200722

PR0701 Registration of establishment

Comment text: Registration of Establishment

Patent event date: 20200722

Patent event code: PR07011E01D

PR1002 Payment of registration fee

Payment date: 20200723

End annual number: 3

Start annual number: 1

PG1601 Publication of registration
PR1001 Payment of annual fee

Payment date: 20240625

Start annual number: 5

End annual number: 5